Uronova Pharmaceuticals, Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 85043 (Uronova Pharmaceuticals, Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
5
Package NDCs
8
Products
8
Active listings
0
Discontinued
1
Ingredients
0
Therapeutic classes
1
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 8 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Vabrinty Leuprolide acetate 7.5 mg/.25mL INJECTION, SUSPENSION, EXTENDED RELEASE | 85043-0075-05 | — | On market | View → |
| Vabrinty Leuprolide acetate 22.5 mg/.375mL INJECTION, SUSPENSION, EXTENDED RELEASE | 85043-0025-02 | — | On market | View → |
| Vabrinty Leuprolide acetate 30 mg/.5mL INJECTION, SUSPENSION, EXTENDED RELEASE | 85043-0030-03 | — | On market | View → |
| Vabrinty Leuprolide acetate 45 mg/.375mL INJECTION, SUSPENSION, EXTENDED RELEASE | 85043-0045-04 | — | On market | View → |
| Vabrinty Leuprolide acetate 22.5 mg/.375mL INJECTION, SUSPENSION, EXTENDED RELEASE | 85043-0025-02 | — | On market | View → |
| Vabrinty Leuprolide acetate 30 mg/.5mL INJECTION, SUSPENSION, EXTENDED RELEASE | 85043-0030-03 | — | On market | View → |
| Vabrinty Leuprolide acetate 45 mg/.375mL INJECTION, SUSPENSION, EXTENDED RELEASE | 85043-0045-04 | — | On market | View → |
| Vabrinty Leuprolide acetate 7.5 mg/.25mL INJECTION, SUSPENSION, EXTENDED RELEASE | 85043-0075-05 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.